UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 362 - 364
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Neoplasm, Residual - drug therapy | Neoplasm Recurrence, Local - drug therapy | Female | Male | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 31, pp. 5195 - 5201
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Prognosis | Gene Expression - drug effects | Humans | Middle Aged | Risk Factors | Child, Preschool | Neoplasm, Residual - genetics | Young Adult | Leukemia, Myeloid, Acute - diagnosis | Genes, Wilms Tumor | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | DNA Mutational Analysis | Reverse Transcriptase Polymerase Chain Reaction - methods | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Adult | Aged | Biomarkers, Tumor - genetics | Child | Leukemia, Myeloid, Acute - genetics | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2008, Volume 111, Issue 5, pp. 2527 - 2537
Life Sciences & Biomedicine | Hematology | Science & Technology | Protein Structure, Tertiary | Recurrence | Prognosis | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Survival Rate | Genetic Markers | Mutation - genetics | fms-Like Tyrosine Kinase 3 - chemistry | Leukemia, Myeloid, Acute - mortality | fms-Like Tyrosine Kinase 3 - genetics | Thermodynamics | Leukemia, Myeloid, Acute - diagnosis | DNA Mutational Analysis | Karyotyping | Adolescent | Aged, 80 and over | Adult | Aged | Neoplasm Proteins - genetics | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2005, Volume 106, Issue 12, pp. 3733 - 3739
Life Sciences & Biomedicine | Hematology | Science & Technology | Prognosis | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | DNA Mutational Analysis | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Mutation | Nuclear Proteins - genetics | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 19, pp. 2428 - 2436
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Leukemia, Myelomonocytic, Chronic - diagnosis | Predictive Value of Tests | Prognosis | Humans | Leukemia, Myelomonocytic, Chronic - genetics | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Protein Splicing - genetics | Gene Expression Profiling | Adult | Female | Neoplasm Proteins - genetics | Risk Assessment | Leukemia, Myelomonocytic, Chronic - mortality | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Repressor Proteins - genetics | Genotype | Signal Transduction - genetics | Phenotype | Analysis of Variance | Epigenesis, Genetic - genetics | Aged | Mutation | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 24, pp. 2305 - 2315
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Humans | Middle Aged | Leukemia, Hairy Cell - genetics | Male | MAP Kinase Kinase Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Lymphoma, B-Cell - genetics | Sequence Analysis, DNA | Leukemia, Hairy Cell - metabolism | Proto-Oncogene Proteins B-raf - genetics | Lymphoma, B-Cell - pathology | Adult | Female | Aged | Mutation | Leukemia, Hairy Cell - pathology | Care and treatment | Genetic aspects | Research | Diagnosis | Gene mutations | Leukemia, Hairy cell | Spleen | Flow cytometry | Hematology | Hairy cells | Leukemia | Extracellular signal-regulated kinase | MAP kinase | Genomes | Kinases | Medical diagnosis | Patients | Lymphoma | Studies | Lymphocytes B | Protein kinase | Genetic analysis | Peripheral blood | Bone marrow | Deoxyribonucleic acid--DNA | Tumors | B-cell lymphoma | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2010, Volume 28, Issue 24, pp. 3858 - 3865
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Proto-Oncogene Proteins c-cbl - genetics | Predictive Value of Tests | ras Proteins - genetics | Prognosis | Humans | Leukemia, Myelomonocytic, Chronic - genetics | Middle Aged | Kaplan-Meier Estimate | Male | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Adult | Female | Aged | Mutation | Genes, ras | Core Binding Factor Alpha 2 Subunit - genetics | Sequence Analysis, DNA - methods | Index Medicus
Journal Article
Haematologica (Roma), ISSN 0390-6078, 12/2014, Volume 99, Issue 12, pp. e244 - e246
Molecular pattern | aCML | Chronic myelomonocytic leukemia | Chronic neutrophilic leukemia | Life Sciences & Biomedicine | Hematology | Science & Technology | Leukemia, Neutrophilic, Chronic - diagnosis | Leukemia, Myelomonocytic, Chronic - diagnosis | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - diagnosis | Prognosis | Humans | Leukemia, Myelomonocytic, Chronic - genetics | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - genetics | Female | Male | Biomarkers, Tumor - genetics | Leukemia, Neutrophilic, Chronic - genetics | Mutation - genetics | Index Medicus | Online Only | chronic neutrophilic leukemia | molecular pattern | chronic myelomonocytic leukemia
Journal Article
Haematologica (Roma), ISSN 0390-6078, 12/2011, Volume 96, Issue 12, pp. 1799 - 1807
Additional chromosomal alterations | Acute promyelocytic leukemia | FLT3 mutations | Prognosis | FLT3-ITD/wt ratio | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Chromosome aberrations | Medical genetics | Translocation, Genetic | Tretinoin - administration & dosage | Humans | Middle Aged | Male | Survival Rate | Antineoplastic Agents - administration & dosage | Chromosomes, Human, Pair 15 - genetics | Chromosomes, Human, Pair 17 - genetics | fms-Like Tyrosine Kinase 3 - genetics | Disease-Free Survival | Oncogene Proteins, Fusion - genetics | Leukemia, Promyelocytic, Acute - mortality | Adult | Female | Aged | Leukemia, Promyelocytic, Acute - genetics | Leukemia, Promyelocytic, Acute - drug therapy | Index Medicus | acute promyelocytic leukemia | FLT3-ITD | wt ratio | additional chromosomal alterations | Original | prognosis
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 5, pp. 415 - 423
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Piperazines - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Young Adult | Benzamides - administration & dosage | Time Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Aged, 80 and over | Adult | Female | Benzamides - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Pyrimidines - administration & dosage | Risk Factors | Proportional Hazards Models | Treatment Outcome | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Disease Progression | Interferon-alpha - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Fusion Proteins, bcr-abl - metabolism | Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 03/2001, Volume 27, Issue 3, pp. 263 - 270
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Sequence Deletion | DNA, Neoplasm - metabolism | Leukemia, Myeloid, Acute - pathology | Humans | Leukemia, Myeloid, Acute - metabolism | Transcriptional Activation | DNA Primers - genetics | CCAAT-Enhancer-Binding Protein-alpha - chemistry | Cell Differentiation - genetics | CCAAT-Enhancer-Binding Protein-alpha - biosynthesis | Cell Nucleus - metabolism | Genes, Dominant | Base Sequence | CCAAT-Enhancer-Binding Protein-alpha - genetics | Granulocytes - pathology | Heterozygote | Mutation | In Vitro Techniques | Leukemia, Myeloid, Acute - genetics | Neutrophils - pathology | CCAAT/enhancer binding protein-^a | CEBPA gene | Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 01/2013, Volume 45, Issue 1, pp. 18 - 24
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Amino Acid Sequence | Prognosis | Histone Chaperones - genetics | Humans | Histone Chaperones - metabolism | Molecular Sequence Data | Nuclear Proteins - metabolism | Transcription Factors - genetics | Sequence Analysis, DNA | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - mortality | Amino Acid Motifs | Exome | Transcription Factors - metabolism | Carrier Proteins - genetics | Carrier Proteins - metabolism | Protein Phosphatase 2 - metabolism | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - genetics | Protein Binding | Protein Interaction Domains and Motifs | Mutation | Nuclear Proteins - genetics | Amino Acid Substitution | Gene mutations | Genetic aspects | Chronic myeloid leukemia | Research | Health aspects | Oncogenes | Cancer | Proteins | Databases | Pathogenesis | Genetic testing | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article